Inspiration Point | Pharma

IMPORTANT NOTICES: Any medical information on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a licensed healthcare professional.

Any licensed healthcare professional in a healthcare encounter must independently make decisions on medical testing, diagnosis, medication prescribing, and treatment administration based upon their professional judgement and training regardless of the information on this website.

hand writing with blue marker on glass the word update

This study evaluated the long-term efficacy of lebrikizumab in patients with moderate-to-severe atop...

Hand writing update with blue marker on a glass

hand with blue marker writing the word update on glass

Researchers at the National Institutes of Health (NIH) have uncovered new insights into dermatitis c...

hand writing on glass with blue marker the word update

Deucravacitinib demonstrated a consistent safety profile over 5 years with more than 5,000 patient y...

Hand writing update with blue marker on a glass

As a dermatology physician assistant (PA), staying at the forefront of clinical advancements is key ...

A small cohort of 12 patients undergoing long-term maintenance therapy with baricitinib 4-mg for alo...

PROSES Study Evaluating Impact of Sarecycline

The Patient-Reported Outcomes in Actinic Keratosis (PROAK) study investigated the effectiveness and ...

The FDA has accepted Arcutis Biotherapeutics' Supplemental New Drug Application for ZORYVE® (roflumi...